Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis

被引：16

作者：

Jones, EA ^{[1
]}

机构：

[1] Acad Med Ctr, Dept Gastrointestinal & Liver Dis, NL-1105 AZ Amsterdam, Netherlands

来源：

HEPATOLOGY | 2002年 / 35卷 / 02期

关键词：

D O I：

10.1053/jhep.2002.31607

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：258 / 262

页数：5

共 51 条

[1]

EFFECT OF MYCOPHENOLIC-ACID ON EPSTEIN-BARR-VIRUS INFECTION OF HUMAN B-LYMPHOCYTES [J].

ALFIERI, C ;

ALLISON, AC ;

KIEFF, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) :126-129

[2]

ALLISON AC, 1975, LANCET, V2, P1179

[3]

IMMUNOSUPPRESSIVE AND OTHER EFFECTS OF MYCOPHENOLIC-ACID AND AN ESTER PRODRUG, MYCOPHENOLATE MOFETIL [J].

ALLISON, AC ;

EUGUI, EM .

IMMUNOLOGICAL REVIEWS, 1993, 136 :5-28

[4]

Mycophenolate mofetil and its mechanisms of action [J].

Allison, AC ;

Eugui, EM .

IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :85-118

[5]

Bach N, 1998, HEPATOLOGY, V28, p545A

[6]

DIMINISHED SURVIVAL IN ASYMPTOMATIC PRIMARY BILIARY-CIRRHOSIS - A PROSPECTIVE-STUDY [J].

BALASUBRAMANIAM, K ;

GRAMBSCH, PM ;

WIESNER, RH ;

LINDOR, KD ;

DICKSON, ER .

GASTROENTEROLOGY, 1990, 98 (06) :1567-1571

[7]

Bergasa NV, 1996, AM J GASTROENTEROL, V91, P295

[8]

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration [J].

Bullingham, R ;

Monroe, S ;

Nicholls, A ;

Hale, M .

JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04) :315-324

[9]

Clinical pharmacokinetics of mycophenolate mofetil [J].

Bullingham, RES ;

Nicholls, AJ ;

Kanmm, BR .

CLINICAL PHARMACOKINETICS, 1998, 34 (06) :429-455

[10]

Bullingham RES, 1996, TRANSPLANT P, V28, P925

← 1 2 3 4 5 6 →